ÆÐÇ÷Áõ Áø´Ü ½ÃÀå : Á¦Ç° À¯Çüº°, ¹æ¹ýº°, º´¿øÃ¼º°, ±â¼úº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Sepsis Diagnostics Market, By Product Type, By Method, By Pathogen, By Technology, By End User, By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
»óǰÄÚµå : 1789630
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,351,000
Unprintable PDF & Excel (Single User License)
US $ 7,000 £Ü 9,880,000
PDF & Excel (Multi User License - Up to 7 Users)
US $ 10,000 £Ü 14,115,000
PDF & Excel (Corporate User License)


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÆÐÇ÷Áõ Áø´Ü ½ÃÀåÀº 2025³â¿¡´Â 10¾ï 1,580¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 19¾ï 6,690¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³âÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 9.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸®Æ÷Æ® ¹üÀ§ ¸®Æ÷Æ® »ó¼¼
±âÁØ¿¬µµ 2024 2025³â ½ÃÀå ±Ô¸ð 10¾ï 1,580¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR : 9.90% 2032³â °¡Ä¡ ¿¹Ãø 19¾ï 6,690¸¸ ´Þ·¯

ÆÐÇ÷ÁõÀº °¨¿°¿¡ ´ëÇÑ ½ÅüÀÇ ¹ÝÀÀÀÌ Àü½Å¿¡ ¿°Áõ ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â ÁúȯÀÔ´Ï´Ù. ¸é¿ª°è´Â º´¿ø±ÕÀ» ü¿Ü·Î ¹èÃâÇϱâ À§ÇØ ¿°Áõ¼º È­Çй°ÁúÀ» Ç÷·ù·Î ¹æÃâÇÏÁö¸¸, ÀÌ È­Çй°ÁúÀÌ ¿¬¼â¹ÝÀÀÀ» ÀÏÀ¸ÄÑ Àå±â ¼Õ»óÀ» À¯¹ßÇÏ°í ¶§·Î´Â »ý¸íÀ» À§ÇùÇϱ⵵ ÇÕ´Ï´Ù. ÆÐÇ÷ÁõÀÇ Áõ»óÀ¸·Î´Â Ç÷¾Ð ÀúÇÏ, Á¤½Å Âø¶õ, ¹ß¿­, ½É¹Ú¼ö Áõ°¡, È£Èí°ï¶õ µîÀÌ ÀÖ½À´Ï´Ù. ÆÐÇ÷ÁõÀº ¼¼±Õ, ¹ÙÀÌ·¯½º, °õÆÎÀÌ µîÀÇ °¨¿° ¿äÀο¡ ÀÇÇØ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ÆÐÇ÷ÁõÀÇ À§ÇèÀ» ³ôÀÌ´Â ¿äÀÎÀ¸·Î´Â °í·É, ´ç´¢º´, °£Áúȯ, Ç×»ýÁ¦ »ç¿ë, Ä«Å×ÅÍ¿Í °°Àº ħ½ÀÀû ÀÇ·á±â±¸ »ç¿ë µîÀÌ ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

½ÃÀå °³¹ß ±â¾÷Àº º¸´Ù È¿À²ÀûÀÎ ÆÐÇ÷Áõ Áø´Ü ½Ã½ºÅÛ °³¹ßÀ» À§ÇØ ÀÓ»ó½ÃÇèÀ» ÁøÇàÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹ ͏®Æ÷´Ï¾ÆÀÇ Áø´Ü ±â¾÷ ÀÎÇ÷¹¸Åƽ½º(Inflammatix, Inc.)´Â 2020³â 2¿ù 1,500¸íÀ» ´ë»óÀ¸·Î ÀÚ»ç Á¦Ç°ÀÎ HostDx Sepsis¿¡ ´ëÇÑ ÀÓ»ó½ÃÇè ¿¬±¸¸¦ ½ÃÀÛÇßÀ¸¸ç, 2021³â 11¿ù±îÁö ¿Ï·áÇÒ ¿¹Á¤ÀÔ´Ï´Ù. ÀÌ ÀÓ»ó½ÃÇèÀº ÆÐÇ÷ÁõÀÌ ÀǽɵǴ ȯÀÚÀÇ Áø´Ü ¹× ¿¹ÈÄ¿¡ ´ëÇÑ HostDx Sepsis Áø´Ü °Ë»çÀÇ ¼º´ÉÀ» Á¶»çÇÏ´Â ÀÓ»ó½ÃÇèÀÔ´Ï´Ù.

½ÃÀå ÁøÃâ±â¾÷Àº À¯ÅëÀ» °­È­Çϱâ À§ÇØ Å¸»ç¿ÍÀÇ Á¦ÈÞ¸¦ ÃßÁøÇÏ´Â µî ¼¼°è ÀÔÁö¸¦ È®´ëÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¼¼°è ÆÐÇ÷Áõ Áø´Ü ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹¸¦ µé¾î 2020³â 5¿ù BARDA(Biomedical Advanced Research and Development Authority)¿Í ¹Ì±¹ ͏®Æ÷´Ï¾Æ¿¡ º»»ç¸¦ µÐ »ýÀÇÇÐ °Ë»ç ¼Ö·ç¼Ç ÇÁ·Î¹ÙÀÌ´õÀÎ Beckman Coulter Inc. COVID-19 ȯÀÚÀÇ ÆÐÇ÷Áõ Á¶±â ¹ß°ßÀ» À§ÇÑ Áø´Ü ¾Ë°í¸®Áò °³¹ßÀ» À§ÇÑ Àü·«Àû Á¦ÈÞ¸¦ ü°áÇß½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ÆÐÇ÷Áõ Áø´Ü ½ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â

Á¦5Àå ¼¼°èÀÇ ÆÐÇ÷Áõ Áø´Ü ½ÃÀå, ¹æ¹ýº°, 2020-2032³â

Á¦6Àå ¼¼°èÀÇ ÆÐÇ÷Áõ Áø´Ü ½ÃÀå, º´¿øÃ¼º°, 2020-2032³â

Á¦7Àå ¼¼°èÀÇ ÆÐÇ÷Áõ Áø´Ü ½ÃÀå, ±â¼úº°, 2020-2032³â

Á¦8Àå ¼¼°èÀÇ ÆÐÇ÷Áõ Áø´Ü ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â

Á¦9Àå ¼¼°èÀÇ ÆÐÇ÷Áõ Áø´Ü ½ÃÀå, Áö¿ªº°, 2020-2032³â

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ¼½¼Ç

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Sepsis Diagnostics Market is estimated to be valued at USD 1,015.8 Mn in 2025 and is expected to reach USD 1,966.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1,015.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.90% 2032 Value Projection: USD 1,966.9 Mn

Sepsis is a condition wherein the body's response to infection triggers an inflammation reaction throughout the body. The immune system releases inflammatory chemicals into the bloodstream to clear out pathogens from the body, but instead these chemicals cause a cascade of reactions that result in organ damage and may be fatal. A few of the symptoms of sepsis include low blood pressure, mental confusion, fever, an increased heart rate, and difficulty breathing. Sepsis may be caused by infectious agents such as bacteria, viruses, and fungi. Several factors that increase the risk of sepsis include old age, diabetes, liver disease, the use of antibiotics, and the use of invasive medical devices such as catheters.

Market Dynamics

Market players are conducting clinical trials for developing more efficient diagnostic systems for sepsis, which could contribute to the growth of the market over the forecast period. For instance, in February 2020, Inflammatix, Inc., a California, U.S. based diagnostics company, initiated a clinical trial study for their product HostDx Sepsis with 1500 participants, which is expected to be completed by November 2021. This clinical study investigates the performance of the HostDx Sepsis diagnostic test in the diagnosis and prognosis of patients with suspected sepsis.

Market players are involved in expanding their presence globally by entering into collaboration with other companies in order to enhance distribution, which is expected to drive the growth of the global sepsis diagnostics market. For instance, in May 2020, BARDA (Biomedical Advanced Research and Development Authority) and Beckman Coulter Inc., a California, U.S. based biomedical testing solutions provider, entered into a strategic collaboration for the development of a diagnostic algorithm for early detection of sepsis in COVID-19 patients.

Key features of the study

Market Segmentation

Table of Contents

1. Research Objective and Assumption

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Sepsis Diagnostics Market, By Product Type, 2020-2032, (USD Mn)

5. Global Sepsis Diagnostics Market, By Method, 2020 - 2032, (USD Mn)

6. Global Sepsis Diagnostics Market, By Pathogen, 2020 - 2032, (USD Mn)

7. Global Sepsis Diagnostics Market, By Technology, 2020 - 2032, (USD Mn)

8. Global Sepsis Diagnostics Market, By End User, 2020 - 2032, (USD Mn)

9. Global Sepsis Diagnostics Market, By Region, 2020 - 2032, (USD Mn)

10. Competitive Landscape

11. Section

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â